Pharmaceutical Executive-06-01-2008
Pharmaceutical Executive
When it comes to marketing, every syllable speaks volumes
Pharmaceutical Executive
S
Pharmaceutical Executive
EU makes plans to police its supply chain
Pharmaceutical Executive
Everyone makes mistakes; how you handle them is the measure of a true leader
Pharmaceutical Executive
This time, powerful interest groups (like pharma) that sank the Clinton healthcare bill are on the side of change
Pharmaceutical Executive
Pharma is taking note of online video's power to affect B2B communications
Pharmaceutical Executive
The great debate on DTC advertising is heating up again. We're going to be hearing a lot about fair balance and risk communication and costs. But what about the patients?
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5